Mutation analyses of plasma and tumor DNA in EGFR mutation-positive advanced non-small-cell lung cancer.
Not Applicable
- Conditions
- non-small-cell lung cancer
- Registration Number
- JPRN-UMIN000016879
- Lead Sponsor
- Clinical Research Support Center Kyushu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient with positive HBs antigen or HVC antibody. 2) Patient with definite positive HIV antibody (need not for examination). 3) Any other patients who are regarded as unsuitable for this study by the investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method